-Parties: The applicant was Hoffmann-La Roche Limited (Roche). The respondents included the Minister of Health, the Attorney General of Canada, and Biosimilar Collaborations Ireland Limited (BCIL).

-Subject Matter: This is an application for judicial review before the Federal Court under section 18.1 of the Federal Courts Act, brought by Hoffmann-La Roche Limited in a matter engaging the Patented Medicines (Notice of Compliance) Regulations and naming the Minister of Health, the Attorney General of Canada, and Biosimilar Collaborations Ireland Limited as respondents. At a preliminary stage, the respondent BCIL has brought a motion to strike the application in its entirety, without leave to amend, with a request for elevated-scale costs. The case is ongoing.

-Date: The hearing was set on June 9, 2026.

-Venue: This was a federal case before the Federal Court.

-Amount: No financial award was specified.